Zucara Therapeutics Inc. 


Zucara Therapeutics Inc.

661 University Avenue, Suite 1300, MaRS Centre, JLABS @ Toronto   

Toronto, Ontario           

M5G 0B7

About Zucara Therapeutics Inc. 
Zucara Therapeutics, a spin-off of The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing the first drug therapy to prevent hypoglycemia in people with diabetes. The Company’s first-in-class therapeutic is aimed at inhibiting a hormone in the pancreas called somatostatin, which does not function properly in Type 1 diabetes. Preventing hypoglycemia will dramatically change diabetes disease management, improving both patient health and quality of life. www.zucara.ca